American Urological Association Releases the Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia Guideline

Today, the American Urological Association (AUA) released the 2026 Management of Lower Urinary Tract Symptoms (LUTS) Attributed to Benign Prostatic Hyperplasia (BPH) Guideline, providing updated, ...

Water Vapour Therapy: A Minimally Invasive Breakthrough In Prostate Care

Benign Prostatic Hyperplasia (BPH), or prostate enlargement, is a common condition affecting aging men in India. It often ...
PharmiWeb

Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market 2026 Analysis & Forecast To 2031 By Key Players, Share, Trend, Segmentation, Top Leaders and Regi…

Benign Prostatic Hyperplasia Surgical Treatment Market OverviewThe global benign prostatic hyperplasia surgical treatment ...

Prodeon Medical Highlights the Urocross Expander System Clinical Results at the American Urological Association (AUA) 2026 Annual Meeting

Practice-changing, Paradigm-shifting Clinical Trials in Urology (P2s): A Pivotal, Randomized, Sham-Controlled Trial of the Urocross Expander System for Treatment of LUTS due to BPH – 30 Month Safety ...
Seeking Alpha

Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH

IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NYMXF) [OTC Markets – NYMXF] (the “Company”) is pleased to announce today that a new formal submission has been ...